# A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

> clinical trial · VERIFIED · 2026-06-12

Status: NOT_YET_RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: Tuberculosis

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: infectious disease
- Primary source: https://clinicaltrials.gov/study/NCT07124559

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.